Literature DB >> 22970891

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.

G Ocak1, K J van Stralen, F R Rosendaal, M Verduijn, P Ravani, R Palsson, T Leivestad, A J Hoitsma, M Ferrer-Alamar, P Finne, J De Meester, C Wanner, F W Dekker, K J Jager.   

Abstract

BACKGROUND: It is has been suggested that dialysis patients have lower mortality rates for pulmonary embolism than the general population, because of platelet dysfunction and bleeding tendency. However, there is limited information whether dialysis is indeed associated with a decreased mortality risk from pulmonary embolism.
OBJECTIVE: The aim of our study was to evaluate whether mortality rate ratios for pulmonary embolism were lower than for myocardial infarction and stroke in dialysis patients compared with the general population.
METHODS: Cardiovascular causes of death for 130,439 incident dialysis patients registered in the ERA-EDTA Registry were compared with the cardiovascular causes of death for the European general population.
RESULTS: The age- and sex-standardized mortality rate (SMR) from pulmonary embolism was 12.2 (95% CI 10.2-14.6) times higher in dialysis patients than in the general population. The SMRs in dialysis patients compared with the general population were 11.0 (95% CI 10.6-11.4) for myocardial infarction, 8.4 (95% CI 8.0-8.8) for stroke, and 8.3 (95% CI 8.0-8.5) for other cardiovascular diseases. In dialysis patients, primary kidney disease due to diabetes was associated with an increased mortality risk due to pulmonary embolism (HR 1.9; 95% CI 1.0-3.8), myocardial infarction (HR 4.1; 95% CI 3.4-4.9), stroke (HR 3.5; 95% CI 2.8-4.4), and other cardiovascular causes of death (HR 3.4; 95% CI 2.9-3.9) compared with patients with polycystic kidney disease.
CONCLUSIONS: Dialysis patients were found to have an unexpected highly increased mortality rate for pulmonary embolism and increased mortality rates for myocardial infarction and stroke.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2012        PMID: 22970891     DOI: 10.1111/j.1538-7836.2012.04921.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  19 in total

1.  Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Authors:  Moshe Shashar; Mostafa E Belghasem; Shinobu Matsuura; Joshua Walker; Sean Richards; Faisal Alousi; Keshab Rijal; Vijaya B Kolachalama; Mercedes Balcells; Minami Odagi; Kazuo Nagasawa; Joel M Henderson; Amitabh Gautam; Richard Rushmore; Jean Francis; Daniel Kirchhofer; Kumaran Kolandaivelu; David H Sherr; Elazer R Edelman; Katya Ravid; Vipul C Chitalia
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

Review 2.  Thrombosis and anticoagulation in the setting of renal or liver disease.

Authors:  Christine Ribic; Mark Crowther
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Healthcare burden of venous thromboembolism in childhood chronic renal diseases.

Authors:  Bryce A Kerlin; William E Smoyer; James Tsai; Sheree L Boulet
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

4.  Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.

Authors:  Jeffrey J W Verschuren; Gurbey Ocak; Friedo W Dekker; Ton J Rabelink; J Wouter Jukema; Joris I Rotmans
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

5.  Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.

Authors:  Atul Kumar; Wen-Chen Tsai; Tai-Sheng Tan; Li-Ting Chiu; Pei-Tseng Kung; Ching-Kan Lo; Ming-Chou Ku
Journal:  Clin Orthop Relat Res       Date:  2015-11-13       Impact factor: 4.176

6.  Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.

Authors:  Yueh-Han Hsu; Hsuan-Ju Chen; Szu-Ching Shen; Wen-Chen Tsai; Chih-Cheng Hsu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

7.  Fatal pulmonary embolism after hemodialysis vascular access declotting.

Authors:  Seyed-Ali Sadjadi; Maryam Sharif-Hassanabadi
Journal:  Am J Case Rep       Date:  2014-04-28

8.  Changes in the Risk of Stroke in Dialysis Patients: A Retrospective Analysis over the Last 40 Years.

Authors:  Toshiya Aono; Yuki Shinya; Satoru Miyawaki; Takehiro Sugiyama; Isao Kumagai; Atsumi Takenobu; Masahiro Shin; Nobuhito Saito; Akira Teraoka
Journal:  Toxins (Basel)       Date:  2021-05-13       Impact factor: 4.546

9.  Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.

Authors:  Vijaya B Kolachalama; Moshe Shashar; Faisal Alousi; Sowmya Shivanna; Keshab Rijal; Mostafa E Belghasem; Joshua Walker; Shinobu Matsuura; Gary H Chang; C Michael Gibson; Laura M Dember; Jean M Francis; Katya Ravid; Vipul C Chitalia
Journal:  J Am Soc Nephrol       Date:  2018-01-17       Impact factor: 14.978

10.  A Real-Time Monitoring System to Assess the Platelet Aggregatory Capacity of Components of a Tissue-Engineered Blood Vessel Wall.

Authors:  Faiza Idris Musa; Alan G S Harper; Ying Yang
Journal:  Tissue Eng Part C Methods       Date:  2016-06-27       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.